Biogelx welcomes new CEO to accelerate growth in 3d biomaterials
Insider.co.uk - 23-Jan-2028Mitch Scanlan brings extensive industry experience to lead Biogelx’s expansion of hydrogels
Investments News
Neuralink raised $600 million, reaching a $9 billion valuation
Longevity Technology - 28-May-2025The company is still in early stages but attracting strong investor interest
Maxwell’s AI platform drives revenue growth through health innovation
Live Forever Club - 27-May-2025India partnerships and FDA progress boost future income
Altos Labs expands longevity portfolio with Dorian Therapeutics acquisition
Longevity Technology - 23-May-2025Dorian’s anti-senescence tech adds firepower to Altos Labs’ rejuvenation strategy
Tomorrow.Bio raises 5m to bring cryonics and life-after-death hopes to the U.S.
EU-Startups - 22-May-2025Berlin startup freezes bodies, hoping for future revival
UK biotech Juvenescence secures over $150m to develop therapies
Endpoints News - 21-May-2025Juvenescence expands pipeline and UAE presence with new funding to tackle age-related diseases
23andMe’s fall from fame ends in Regeneron takeover
BBC - 19-May-2025Regeneron buys 23andMe for $256M, pledges to protect user data and boost drug discovery
AI startup Somite raises $47m to revolutionize stem cell therapy
Longevity Technology - 16-May-2025Somite AI uses DeltaStem to speed up and scale stem cell engineering
BrightFocus Foundation fuels early research on aging diseases with $13m grants
Longevity Technology - 13-May-2025Private funding supports global scientists tackling Alzheimer’s, vision loss, and glaucoma
Rewriting the cell's code: HAYA’s mission to transform genomic medicine
Longevity Technology - 12-May-2025Biotech startup raises $65M to develop RNA therapies that reprogram disease-driving cell states
Xprize longevity contest narrows field to 40 semi-finalists
The Guardian - 11-May-2025Drawn from over 1,000 global contenders, the selected teams are one step closer to the $101M prize
Hundred health acquires BellSant to supercharge AI longevity platform strapline:
Longevity Technology - 08-May-2025AI-driven health platform gears up for launch with cutting-edge longevity data
NewLimit secures $130m to accelerate epigenetic reprogramming for longevity
Longevity Technology - 06-May-2025The biotech company aims to target the root causes of ageing to develop therapies to extend lifespan
Lilly bets big on AI-discovered ALS drug in $415m deal
FierceBiotech - 06-May-2025AI-powered therapy offers new hope for ALS as early trials approach
Biotech shake-up: Unity and Mammoth announce major layoffs amid strategic shifts
FierceBiotech - 05-May-2025Unity exits eye drug race, Mammoth tightens focus on CRISPR pipeline
Recursion overhauls pipeline after key drug fails in mid-stage trial
Endpoints News - 05-May-2025With $509M in cash, biotech bets on fewer, stronger programs ahead of 2025 data
Stately Bio emerges with AI-powered window into living cells
Endpoints News - 01-May-2025AI startup decodes live cell behaviour using simple imaging and machine learning
A brighter path for Parkinson’s: light therapy device nears FDA finish line
Longevity Technology - 28-Apr-2025PhotoPharmics secures $6 million to advance its home-based Celeste device
Catalytic antibodies lose their champion
Fight Aging! - 23-Apr-2025Covalent Biosciences falters amid investor caution, patent expiry, and steep development costs
Biolinq secures $100m to launch needle-free glucose monitor
FierceBiotech - 22-Apr-2025Tracks glucose, activity, and sleep—offering a simpler option for people with Type 2 diabetes
Breakthrough drug targets liver regeneration with 21.5m boost
Longevity Technology - 17-Apr-2025HepaRegeniX advances trials for a novel liver regeneration therapy
AI alliance to redefine the future of ageing and therapeutics
Juvenescence - 16-Apr-2025M42 and Juvenescence join forces to accelerate precision medicine and longevity
Science corp secures major funding to restore sight with BCI tech
Longevity Technology - 15-Apr-2025A next-gen retinal implant offers new hope for vision loss from macular degeneration
New drug for Parkinson’s may keep symptoms under control with just weekly injections
Longevity Technology - 09-Apr-2025It avoids common delivery problems and enters Phase 1 trials in 2025
Switching genes, not sequences: the rise of epigenetic editing
Chemistry World - 09-Apr-2025Precision drugs use chemical tags to control genes without changing DNA
Display all news
